St. Jude Medical Inc. (STJ) said that it has received European CE mark approval for the industry's first quadripolar pacing system for cardiac resynchronization therapy defibrillators or CRT-Ds.
The system offers physicians additional pacing options and more flexibility in selecting pacing configurations during and after implant procedures, the company said.
The quadripolar CRT-D and Quartet pacing lead will be distributed via a limited launched in Europe, and will be used in the investigational devices exemption trial for FDA approval of the commercialized device, which will be called the Promote Quadra CRT-D.
For comments and feedback: editorial@rttnews.com